Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Eledon Pharmaceuticals will deliver an oral presentation at the American Society of Nephrology Kidney Week 2026 meeting in Denver, October 21-25. The presentation will cover patient-reported outcomes from the Phase 2 BESTOW trial comparing tegoprubart to tacrolimus for prevention of rejection in kidney transplant recipients. Dr. Andrew B.
Key figures
- Drug Name
- tegoprubart
- Phase Of Trial
- Phase 2
- Conference
- ASN Kidney Week 2026
- Trial name
- BESTOW
- Presentation date
- 2026-10-23
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.